John Libbey Eurotext

European Journal of Dermatology

MENU

Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis Volume 12, numéro 1, January - February 2002

Auteurs
Department of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
  • Page(s) : 50-2
  • Année de parution : 2002

FK506 (tacrolimus) is an effective immunosuppresant drug for the prevention of rejection after organ transplantation [1]. This agent has also been used for several autoimmune diseases including systemic lupus erythematosus (SLE) [2-4]. Tacrolimus is the prototype of a class of topical immunosuppressive agents with great potential for the treatment of inflammatory skin diseases such as atopic dermatitis, contact dermatitis and alopecia [...]